Last updated: 2026-10-12 20:00:40. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
Cencora, Inc. (COR) operates in the WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES sector and is listed on NYSE. The stock is currently priced at $325,60, with a market capitalization of $61,80B and a P/E ratio of 23,54. Over the past 52 weeks, its price has ranged from $244,82 to $377,54. This page covers its latest market performance, valuation, price trends and company information.
$61,80B | |
$325,37 | |
$377,54 | |
$0,10 | |
$323,85 | |
664,92K | |
1,32M | |
23,54 | |
$377,54 | |
$244,82 | |
0,76% | |
-- |
Cencora, Inc. (COR) is trading at $325,59 in after-hours trading as of 2026-10-12 19:45:00, up 0,54% ($1,74) from the regular-session close of $323,85.
After-hours trading shows how investors are pricing COR after the regular session closes. The current after-hours price is above the regular-session close, indicating positive after-hours sentiment.
Over the past seven days, Cencora, Inc. (COR) moved from $309,78 to $325,60, representing a gain of 5,11% ($15,82).
The stock traded between $300,77 and $327,73 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 1,11 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 60,9%
COR is currently trading at $325,60, placing it 60,9% of the way from its 52-week low of $244,82 to its 52-week high of $377,54. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.
| Industry | WHOLESALE-DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES |
| Employees | 51000 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Cencora, Inc. (COR) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.